Vascudyne Inc

Vascudyne Inc is a biotechnology company based in Minnesota, founded in 2014. The company specializes in engineering and cultivating human tissues to meet various medical needs. Vascudyne develops regenerative biomaterials and biologically engineered tissues aimed at enhancing patient care in fields such as cardiovascular, vascular, neurological, wound care, and aesthetic medicine. The company's core technology platform allows for the growth of human tissues in diverse shapes and sizes, producing 100% biological, regenerative, and non-immunogenic allografts. These engineered tissues are designed to serve as soft tissue repair and replacement solutions that closely mimic natural tissue properties. Vascudyne's product pipeline includes investigational allograft technologies, such as coronary artery bypass conduits and artificial arteries and valves, which are currently undergoing early clinical trials to assess their safety and efficacy. Vascudyne's mission is to lead in tissue engineering by creating innovative regenerative therapies that improve healthcare. Their vision focuses on saving and enhancing lives through biological solutions inspired by nature, supported by a team of experts in tissue engineering.

• Employees 20
• Founded 2011
• Total Funding $27739865